Article

Lnc-TMEM132D-AS1 Confers Acquired Resistance to Osimertinib in Non-Small-Cell Lung Cancer

2022-06-17

Abstract excerpt

<h4>Objective: </h4> Acquired resistance is a major obstacle to the therapeutic efficacy of osimertinib in non-small-cell lung cancer (NSCLC). Current knowledge about the role of long non-coding RNAs (lncRNAs) in this phenomenon is insufficient. Here, we aim to identify candidate lncRNAs associated with acqured resistance to osimertinib in NSCLC, and explore the role and underlying mechanism of one of these lncRNA...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b9a9b2b5-f0ff-5694-8831-b47aefc3c077
DOI: 10.21203/rs.3.rs-1747227/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Lnc-TMEM132D-AS1 Confers Acquired Resistance to Osimertinib in Non-Small-Cell Lung CancerDOI 10.21203/rs.3.rs-1747227/v1Read

Lnc-TMEM132D-AS1 as a potential therapeutic target for acquired resistance to osimertinib in non-small-cell lung cancerSemantic proximity Read

Characterization of circRNAs in established osimertinib‑resistant non‑small cell lung cancer cell linesSemantic proximity Read

Exosomal microRNAs as potential biomarkers for osimertinib resistance of non-small cell lung cancer patientsSemantic proximity Read

Bulk RNA analysis identified the characteristics and immunoinvasive patterns of osimertinib resistance in patients with non-small cell lung cancerSemantic proximity Read

Comprehensive review of LncRNA-mediated therapeutic resistance in non-small cell lung cancerSemantic proximity Read

The functional role of long non-coding RNAs and their underlying mechanisms in drug resistance of non-small cell lung cancerSemantic proximity Read

Long Non-Coding RNA in Drug Resistance of Non-Small Cell Lung Cancer: A Mini ReviewSemantic proximity Read

MicroRNA-130a-3p regulates osimertinib resistance by targeting runt-related transcription factor 3 in lung adenocarcinomaSemantic proximity Read

Exosomal long non-coding RNA MSTRG.292666.16 is associated with osimertinib (AZD9291) resistance in non-small cell lung cancerSemantic proximity Read

Resistance mechanisms to osimertinib and emerging therapeutic strategies in nonsmall cell lung cancer.Semantic proximity Read

Mechanisms analysis for Formononetin counteracted-Osimertinib resistance in Non-small-cell lung cancer cells: from the insight into the gene transcriptional levelSemantic proximity Read

Elevated Exosome-derived Mirnas Predict Osimertinib Resistance in Non-small Cell Lung CancerSemantic proximity Read